INFECTIOUS DISEASE

Pfizer-BioNTech submit COVID-19 vaccine data to FDA for kids 5-11

Pfizer-BioNTech submitted clinical trial data from a COVID-19 vaccine study among kids ages 5-11 to the Food and Drug Administration (FDA), the companies announced Tuesday. A request for emergency approval is anticipated to follow in the coming weeks.